Surgery Partners (SGRY) Competitors

Surgery Partners logo
$26.69 -0.27 (-1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$26.68 -0.02 (-0.06%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SGRY vs. UHS, ENSG, PACS, CON, and ACHC

Should you buy Surgery Partners stock or one of its competitors? Surgery Partners's main competitors and comparable companies include Universal Health Services (UHS), The Ensign Group (ENSG), PACS Group (PACS), Concentra Group Holdings Parent (CON), and Acadia Healthcare (ACHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare facilities" industry.

How does Surgery Partners compare to Universal Health Services?

Surgery Partners (NASDAQ:SGRY) and Universal Health Services (NYSE:UHS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

In the previous week, Surgery Partners had 6 more articles in the media than Universal Health Services. MarketBeat recorded 16 mentions for Surgery Partners and 10 mentions for Universal Health Services. Surgery Partners' average media sentiment score of 0.37 beat Universal Health Services' score of -0.30 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Universal Health Services
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Surgery Partners presently has a consensus price target of $20.70, suggesting a potential downside of 23.22%. Universal Health Services has a consensus price target of $202.60, suggesting a potential upside of 8.85%. Given Universal Health Services' stronger consensus rating and higher probable upside, analysts plainly believe Universal Health Services is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.08
Universal Health Services
1 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.28

Universal Health Services has a net margin of 7.96% compared to Surgery Partners' net margin of -2.59%. Universal Health Services' return on equity of 18.39% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.59% 0.98% 0.38%
Universal Health Services 7.96%18.39%8.61%

Universal Health Services has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Universal Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B1.07-$77.90M-$0.68N/A
Universal Health Services$18.35B0.58$1.49B$23.917.78

86.1% of Universal Health Services shares are held by institutional investors. 2.0% of Surgery Partners shares are held by insiders. Comparatively, 17.1% of Universal Health Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Surgery Partners has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Universal Health Services has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

Summary

Universal Health Services beats Surgery Partners on 11 of the 16 factors compared between the two stocks.

How does Surgery Partners compare to The Ensign Group?

Surgery Partners (NASDAQ:SGRY) and The Ensign Group (NASDAQ:ENSG) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

The Ensign Group has a net margin of 7.03% compared to Surgery Partners' net margin of -2.59%. The Ensign Group's return on equity of 16.79% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.59% 0.98% 0.38%
The Ensign Group 7.03%16.79%7.07%

The Ensign Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B1.07-$77.90M-$0.68N/A
The Ensign Group$5.06B2.11$343.97M$6.7227.23

96.1% of The Ensign Group shares are held by institutional investors. 2.0% of Surgery Partners shares are held by company insiders. Comparatively, 4.0% of The Ensign Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Surgery Partners currently has a consensus target price of $20.70, suggesting a potential downside of 23.22%. The Ensign Group has a consensus target price of $226.00, suggesting a potential upside of 23.51%. Given The Ensign Group's stronger consensus rating and higher possible upside, analysts plainly believe The Ensign Group is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.08
The Ensign Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Surgery Partners has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, The Ensign Group has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

In the previous week, The Ensign Group had 17 more articles in the media than Surgery Partners. MarketBeat recorded 33 mentions for The Ensign Group and 16 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.37 beat The Ensign Group's score of 0.15 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
The Ensign Group
1 Very Positive mention(s)
0 Positive mention(s)
32 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

The Ensign Group beats Surgery Partners on 13 of the 16 factors compared between the two stocks.

How does Surgery Partners compare to PACS Group?

Surgery Partners (NASDAQ:SGRY) and PACS Group (NYSE:PACS) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

PACS Group has a net margin of 4.87% compared to Surgery Partners' net margin of -2.59%. PACS Group's return on equity of 31.98% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.59% 0.98% 0.38%
PACS Group 4.87%31.98%6.07%

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B1.07-$77.90M-$0.68N/A
PACS Group$5.71B1.29$191.54M$1.7726.14

Surgery Partners currently has a consensus price target of $20.70, indicating a potential downside of 23.22%. PACS Group has a consensus price target of $62.50, indicating a potential upside of 35.11%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.08
PACS Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

Surgery Partners has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.14, meaning that its share price is 114% less volatile than the broader market.

In the previous week, Surgery Partners had 6 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for Surgery Partners and 10 mentions for PACS Group. Surgery Partners' average media sentiment score of 0.37 beat PACS Group's score of 0.26 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
2 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

PACS Group beats Surgery Partners on 10 of the 14 factors compared between the two stocks.

How does Surgery Partners compare to Concentra Group Holdings Parent?

Surgery Partners (NASDAQ:SGRY) and Concentra Group Holdings Parent (NYSE:CON) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Concentra Group Holdings Parent has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B1.07-$77.90M-$0.68N/A
Concentra Group Holdings Parent$2.16B2.48$166.41M$1.6924.87

In the previous week, Surgery Partners had 3 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 16 mentions for Surgery Partners and 13 mentions for Concentra Group Holdings Parent. Concentra Group Holdings Parent's average media sentiment score of 0.71 beat Surgery Partners' score of 0.37 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concentra Group Holdings Parent
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Surgery Partners has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Concentra Group Holdings Parent has a net margin of 9.26% compared to Surgery Partners' net margin of -2.59%. Concentra Group Holdings Parent's return on equity of 48.11% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.59% 0.98% 0.38%
Concentra Group Holdings Parent 9.26%48.11%7.49%

Surgery Partners currently has a consensus price target of $20.70, indicating a potential downside of 23.22%. Concentra Group Holdings Parent has a consensus price target of $46.00, indicating a potential upside of 9.46%. Given Concentra Group Holdings Parent's stronger consensus rating and higher probable upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.08
Concentra Group Holdings Parent
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10

Summary

Concentra Group Holdings Parent beats Surgery Partners on 11 of the 15 factors compared between the two stocks.

How does Surgery Partners compare to Acadia Healthcare?

Acadia Healthcare (NASDAQ:ACHC) and Surgery Partners (NASDAQ:SGRY) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Acadia Healthcare currently has a consensus price target of $32.54, indicating a potential downside of 13.44%. Surgery Partners has a consensus price target of $20.70, indicating a potential downside of 23.22%. Given Acadia Healthcare's stronger consensus rating and higher possible upside, research analysts clearly believe Acadia Healthcare is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acadia Healthcare
2 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.53
Surgery Partners
1 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.08

Surgery Partners has a net margin of -2.59% compared to Acadia Healthcare's net margin of -33.07%. Acadia Healthcare's return on equity of 6.53% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Acadia Healthcare-33.07% 6.53% 2.33%
Surgery Partners -2.59%0.98%0.38%

Surgery Partners has lower revenue, but higher earnings than Acadia Healthcare. Surgery Partners is trading at a lower price-to-earnings ratio than Acadia Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acadia Healthcare$3.31B1.05-$1.10B-$12.47N/A
Surgery Partners$3.31B1.07-$77.90M-$0.68N/A

Acadia Healthcare has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market.

In the previous week, Surgery Partners had 4 more articles in the media than Acadia Healthcare. MarketBeat recorded 16 mentions for Surgery Partners and 12 mentions for Acadia Healthcare. Acadia Healthcare's average media sentiment score of 1.30 beat Surgery Partners' score of 0.37 indicating that Acadia Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Acadia Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Surgery Partners
5 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Acadia Healthcare beats Surgery Partners on 8 of the 15 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

MetricSurgery PartnersHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.49B$9.68B$7.47B$11.44B
Dividend YieldN/A2.54%2.47%4.64%
P/E Ratio-39.2532.6132.8129.51
Price / Sales1.061.907.995.27
Price / Cash15.7322.7620.8521.62
Price / Book1.203.364.383.65
Net Income-$77.90M$329.93M$3.51B$394.00M
7 Day Performance0.41%-6.70%-6.17%-6.39%
1 Month Performance81.44%-5.41%-7.05%-8.76%
1 Year Performance69.89%14.22%-2.50%-8.47%

Surgery Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGRY
Surgery Partners
1.582 of 5 stars
$26.69
-1.0%
$20.70
-22.4%
+77.6%$3.49B$3.31BN/A16,000
UHS
Universal Health Services
3.8165 of 5 stars
$197.49
+1.0%
$201.00
+1.8%
-18.7%$11.58B$17.36B8.26101,500
ENSG
The Ensign Group
4.5098 of 5 stars
$182.10
+0.6%
$226.00
+24.1%
+2.5%$10.99B$5.06B27.1046,000
PACS
PACS Group
4.4656 of 5 stars
$48.57
-2.1%
$61.33
+26.3%
+219.6%$7.98B$5.29B22.9547,455
CON
Concentra Group Holdings Parent
4.5796 of 5 stars
$42.41
+0.4%
$43.13
+1.7%
+117.7%$5.55B$2.16B25.0913,133

Related Companies and Tools


This page (NASDAQ:SGRY) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners